why choose us

First received: November 10, 2022

Clinical Trial: A Window of Opportunity Study of Patritumab Deruxtecan in Patients With Brain Metastases

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Brain Metastases, Adult

Study Type: INTERVENTIONAL


Official Title: A Window of Opportunity Study of Patritumab Deruxtecan in Patients With Brain Metastases

Brief Summary: The purpose of this study is to determine if the study drug, patritumab deruxtecan (HER3-DXd), can be measured in brain tumor tissue after recieving one dose of patritumab deruxtecan before surgery.

Read more